US EditionCancer-fighting implant shows promise in treating tumors
- Rice University researchers developed an implantable cytokine factory to fight hard-to-treat cancers.
- Current cancer treatments struggle to balance efficacy with minimized toxicity.
- This device, an IL-12 cytokine factory, is placed near tumors and releases interleukin-12.
- Omid Veiseh stated, "IL-12 is particularly impactful compared to other cytokines."
- Preclinical models showed the device safely eliminated tumors, paving the way for FDA application.
41 Articles
41 Articles
Cancer-fighting implant shows promise in treating melanoma, pancreatic and colorectal tumors
A team of researchers from the Rice Biotech Launch Pad at Rice University has developed an implantable "cytokine factory" that safely triggers potent immune responses against hard-to-treat cancers, including metastatic melanoma, pancreatic and colorectal tumors.
Burnaby-based Terry Fox Foundation partners with Lumira Ventures to launch cancer fund
.bh__table, .bh__table_header, .bh__table_cell { border: 1px solid #C0C0C0; } .bh__table_cell { padding: 5px; background-color: #FFFFFF; } .bh__table_cell p { color: #2D2D2D; font-family: 'Helvetica',Arial,sans-serif !important; overflow-wrap: break-word; } .bh__table_header { padding: 5px; background-color:#F1F1F1; } .bh__table_header p { color: #2A2A2A; font-family:'Trebuchet MS','Lucida Grande',Tahoma,sans-serif !important; overflow-wrap: bre…
Coverage Details
Bias Distribution
- 52% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
